Burgundy Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-25,985
Closed -$768K 106
2014
Q4
$768K Hold
25,985
0.01% 95
2014
Q3
$729K Buy
25,985
+1,669
+7% +$46.8K 0.01% 94
2014
Q2
$685K Hold
24,316
0.01% 100
2014
Q1
$741K Sell
24,316
-5,618
-19% -$168K 0.01% 98
2013
Q4
$870K Buy
29,934
+5,270
+21% +$153K 0.01% 97
2013
Q3
$672K Buy
24,664
+75
+0.3% +$2.04K 0.01% 96
2013
Q2
$653K Buy
+24,589
New +$679K 0.01% 101

Other funds holding PFE

Burgundy Asset Management's PFE Position: Q1 2015 in Review

Burgundy Asset Management sold out of Pfizer (PFE) in Q1 2015, closing a stake of 25,985 shares — an estimated $768K sold.

Burgundy Asset Management first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $870K in Q4 2013. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Burgundy Asset Management reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
  • Burgundy Asset Management sold 25,985 Pfizer shares in Q1 2015, an estimated $768K.
  • Burgundy Asset Management first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Burgundy Asset Management's Pfizer position peaked at $870K in Q4 2013.
  • 1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Burgundy Asset Management's 13F filing for Q1 2015, filed 12 May 2015.